Cargando…

Comparison of multidrug-resistant acinetobacter and non-acinetobacter infections in terms of outcome in critically ill patients

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Madaan, A, Singh, V, Singh, VJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796638/ http://dx.doi.org/10.1186/2197-425X-3-S1-A129

Ejemplares similares

Comparison of multidrug-resistant Acinetobacter and non-Acinetobacter infections in terms of outcome in critically ill patients
por: Madaan, A, et al.
Publicado: (2014)

Evaluation of outcome in critically ill patients with Acinetobacter baumannii bacteremia
por: Pratikaki, M, et al.
Publicado: (2005)

Multidrug Resistant Acinetobacter
por: Manchanda, Vikas, et al.
Publicado: (2010)

Predictors of multidrug-resistant Acinetobacter baumannii infections: a retrospective analysis in surgical ICU patients
por: Camkiran, A, et al.
Publicado: (2012)

Risk factors to bloodstream infection due multidrug-resistant Results Acinetobacter baumanni in colonized patients in the ICU
por: Passos, R, et al.
Publicado: (2011)

Hypercalcaemia resulting from the use of tigecycline in the treatment of multidrug-resistant Acinetobacter in patients with multiorgan failure
por: Duffy, M, et al.
Publicado: (2007)

Risk factors associated with Acinetobacter baumannii septicemia and its mortality rates in critically ill patients
por: Kontopoulou, K, et al.
Publicado: (2013)

Ozone fumigation successfully controlled and eradicated multidrug-resistant Acinetobacter baumanii from an intensive care unit
por: Stümpfle, R, et al.
Publicado: (2010)

Multidrug-resistant Acinetobacter baumannii susceptible only to colistin outbreak in a cardiac surgical intensive care unit
por: Papadopoulos, K, et al.
Publicado: (2007)

Control of multidrug resistant (MDR) Acinetobacter baumanii outbreak in a pediatric oncology unit by optimizing infection prevention (IP) and control measures
por: Melgar, MA, et al.
Publicado: (2011)

The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection
por: Alenazi, Thamer A., et al.
Publicado: (2023)

Changing resistance pattern for Acinetobacter baumannii through the years
por: Alver, F Alkaya, et al.
Publicado: (2008)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
por: Davis, Kepler A., et al.
Publicado: (2005)

Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin
por: Singh, Rajesh K., et al.
Publicado: (2017)

Increasing trends of Acinetobacter Baumannii infections in Emilia-Romagna, Italy
por: Gagliotti, C, et al.
Publicado: (2011)

P234: Acinetobacter infections in intensive care units in 2011
por: Gül, H, et al.
Publicado: (2013)

Multidrug-resistant Acinetobacter baumannii, Russia
por: Naas, Thierry, et al.
Publicado: (2007)

Multidrug-resistant Acinetobacter meningitis in children
por: Shah, Ira, et al.
Publicado: (2016)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

An outbreak of Acinetobacter baumanii in an ICU: effectiveness of an extensive infection control program
por: Bonizzoli, M, et al.
Publicado: (2006)

Rifampicin and colistin association in the treatment of severe multiresistant Acinetobacter baumannii infections
por: Charra, B, et al.
Publicado: (2008)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

Risk factors at icu admission for multi-resistant acinetobacter baumannii colonization and infection and its prediction capability
por: Vara Arlanzón, R, et al.
Publicado: (2015)

Next-gen sequencing of multi-drug resistant Acinetobacter baumannii to determine antibiotic resistance genotypes
por: Dent, Leon, et al.
Publicado: (2010)

The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections
por: Lim, Seung-Kwan, et al.
Publicado: (2011)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
por: Fournier, Pierre-Edouard, et al.
Publicado: (2006)

Optimal Therapy for Multidrug-Resistant Acinetobacter baumannii
por: Cunha, Burke A.
Publicado: (2010)

Multidrug-Resistant Acinetobacter baumannii Clone, France
por: Bonnin, Rémy A., et al.
Publicado: (2013)

Susceptibility Patterns of Multidrug-Resistant Acinetobacter baumannii
por: Konca, Capan, et al.
Publicado: (2020)

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
por: Sunenshine, Rebecca H., et al.
Publicado: (2007)

Multidrug-resistant Acinetobacter baumannii infection in the intensive care unit
por: Wiwanitkit, Viroj
Publicado: (2014)

Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection
por: PAN, TAO, et al.
Publicado: (2016)

Potential Usefulness of Bacteriophages for the Treatment of Multidrug-Resistant Acinetobacter Infection
por: Raees, Fahad, et al.
Publicado: (2023)

Slow continuous dialysis treatment in septic shockcaused by acinetobacter
por: Sen, S, et al.
Publicado: (2015)

Resistance pattern of Acinetobacter spp. isolated from various clinical samples in and around Kanchipuram
por: Senthamarai, S, et al.
Publicado: (2012)

Emergence of multi drug resistant nonfermentative Acinetobacter spp in a tertiary care hospital
por: Amol, Shyamkuwar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_72pp30fad8t4en3mfa0u451d8s